Angelman Syndrome Clinical Trials in Paris
4 recruitingParis, France
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
Angelman Syndrome
Ultragenyx Pharmaceutical Inc60 enrolled22 locationsNCT07157254
Recruiting
Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman Syndrome
Angelman Syndrome
Assistance Publique - Hôpitaux de Paris60 enrolled1 locationNCT06737718
Recruiting
IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
Beckwith-Wiedemann SyndromePrader-Willi SyndromePseudohypoparathyroidism+6 more
Institut National de la Santé Et de la Recherche Médicale, France2,000 enrolled20 locationsNCT05945576
Recruiting
Phase 1Phase 2
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
Angelman Syndrome
Ionis Pharmaceuticals, Inc.70 enrolled11 locationsNCT05127226